| Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial M Kudo, RS Finn, S Qin, KH Han, K Ikeda, F Piscaglia, A Baron, JW Park, ... The Lancet 391 (10126), 1163-1173, 2018 | 4385 | 2018 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1837* | 2021 |
| Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study D Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ... The Lancet 396 (10243), 27-38, 2020 | 1807 | 2020 |
| Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial SJ Antonia, JA López-Martin, J Bendell, PA Ott, M Taylor, JP Eder, ... The Lancet Oncology 17 (7), 883-895, 2016 | 1290 | 2016 |
| The role of focal-adhesion kinase in cancer—a new therapeutic opportunity GW McLean, NO Carragher, E Avizienyte, J Evans, VG Brunton, ... Nature Reviews Cancer 5 (7), 505-515, 2005 | 1227 | 2005 |
| Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity E Volz, V Hill, JT McCrone, A Price, D Jorgensen, Á O’Toole, J Southgate, ... Cell 184 (1), 64-75. e11, 2021 | 1059 | 2021 |
| A unified classification of alien species based on the magnitude of their environmental impacts TM Blackburn, F Essl, T Evans, PE Hulme, JM Jeschke, I Kühn, ... PLoS biology 12 (5), e1001850, 2014 | 961 | 2014 |
| CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma CW Steele, SA Karim, JDG Leach, P Bailey, R Upstill-Goddard, L Rishi, ... Cancer cell 29 (6), 832-845, 2016 | 754 | 2016 |
| Outcome of pregnancy in a woman with an increased body mass index TS Usha Kiran, S Hemmadi, J Bethel, J Evans BJOG: an international journal of obstetrics & gynaecology 112 (6), 768-772, 2005 | 749 | 2005 |
| Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer JP Morton, P Timpson, SA Karim, RA Ridgway, D Athineos, B Doyle, ... Proceedings of the National Academy of Sciences 107 (1), 246-251, 2010 | 731 | 2010 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 660 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 614* | 2021 |
| SEARCH: a phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma AX Zhu, O Rosmorduc, TRJ Evans, PJ Ross, A Santoro, FJ Carrilho, ... Journal of Clinical Oncology 33 (6), 559-566, 2015 | 593 | 2015 |
| CheckMate-032 study: efficacy and safety of nivolumab and nivolumab plus ipilimumab in patients with metastatic esophagogastric cancer YY Janjigian, J Bendell, E Calvo, JW Kim, PA Ascierto, P Sharma, PA Ott, ... Journal of Clinical Oncology 36 (28), 2836, 2018 | 572 | 2018 |
| Defining the impact of non‐native species JM Jeschke, S Bacher, TM Blackburn, JTA Dick, F Essl, T Evans, ... Conservation biology 28 (5), 1188-1194, 2014 | 506 | 2014 |
| Phase I study of the poly (ADP-ribose) polymerase inhibitor, AG014699, in combination with temozolomide in patients with advanced solid tumors R Plummer, C Jones, M Middleton, R Wilson, J Evans, A Olsen, N Curtin, ... Clinical cancer research 14 (23), 7917-7923, 2008 | 488 | 2008 |
| Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study RA Evans, H McAuley, EM Harrison, A Shikotra, A Singapuri, M Sereno, ... The Lancet Respiratory Medicine 9 (11), 1275-1287, 2021 | 469 | 2021 |
| Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind … T Meyer, R Fox, YT Ma, PJ Ross, MW James, R Sturgess, C Stubbs, ... The lancet Gastroenterology & hepatology 2 (8), 565-575, 2017 | 437 | 2017 |
| Early and late complications after pancreatic necrosectomy S Connor, N Alexakis, MGT Raraty, P Ghaneh, J Evans, M Hughes, ... Surgery 137 (5), 499-505, 2005 | 423 | 2005 |
| Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label … G Middleton, P Silcocks, T Cox, J Valle, J Wadsley, D Propper, F Coxon, ... The Lancet Oncology 15 (8), 829-840, 2014 | 381 | 2014 |
